April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Intravenous Pilocarpine Stimulated Accommodation in Rhesus Monkeys
Author Affiliations & Notes
  • M. Wendt
    College of Optometry, University of Houston, Houston, Texas
  • A. Glasser
    College of Optometry, University of Houston, Houston, Texas
  • Footnotes
    Commercial Relationships  M. Wendt, None; A. Glasser, None.
  • Footnotes
    Support  NEI grant RO1 EY014651 and NEI P30 EY07551
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 2794. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Wendt, A. Glasser; Intravenous Pilocarpine Stimulated Accommodation in Rhesus Monkeys. Invest. Ophthalmol. Vis. Sci. 2009;50(13):2794.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Topically administered pilocarpine has been used to stimulate accommodation in both humans and monkeys. However, the concentrations of pilocarpine used, the methods of administration and the results achieved have varied. Here we examine the effectiveness of intravenous (IV) pilocarpine administration in stimulating accommodation in anesthetized rhesus monkeys.

Methods: : Experiments were performed on 6 anesthetized rhesus monkeys aged 5 to 16 years with iridectomized eyes. Maximum accommodation was stimulated with a 2% pilocarpine solution maintained topically on the cornea for at least 30 minutes in a specially designed ocular perfusion lens. In IV experiments, pilocarpine was given as either boluses ranging from 0.25 mg/kg to 2 mg/kg over 30 seconds or as boluses followed by constant infusion with rates of between 3.06 mg/kg/hr and 12.25 mg/kg/hr. Accommodative responses were measured dynamically with photorefraction in one eye and continuous ultrasound biometry in the other eye.

Results: : Constant 2% topically applied pilocarpine in the perfusion lens produced 12.7D ± 2.8 (mean ± SD). A mean accommodative amplitude of 9.2D ± 1.8 (mean ± SD) was achieved with 1.0 mg/kg IV boluses. IV pilocarpine boluses achieved nearly maximal accommodation at least ten times faster than topical methods. Responses to IV pilocarpine boluses had short, dose-dependent durations which were typically less than 5 minutes for sub-maximal doses. IV bolus doses required to achieve maximum accommodation ranged from 0.25 mg/kg to 1.0 mg/kg. IV pilocarpine boluses cause anterior movement of the anterior lens surface, posterior movement of the posterior lens surface, and slight net anterior movements of the entire lens. Constant IV pilocarpine infusions achieved sustained accommodation for more than 45 minutes and were between 57% and 96% of maximum accommodation achieved for the same monkey using constant topical perfusion.

Conclusions: : IV pilocarpine boluses cause rapid, short duration responses. Sustained accommodation can be achieved with IV boluses followed by constant infusion. IV pilocarpine is a reliable method of producing a normal, sustained, and nearly maximal accommodative response in anesthetized monkeys.

Keywords: accomodation • presbyopia 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.